Get started
Work

Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs

Year: 2023
Type: editorial
Abstract: Radioactive iodine-131 (RAI) therapy of metastatic well-differentiated thyroid cancer (mDTC) has been a cornerstone of nuclear medicine practice since it was first conceptualized in the 1940s by Saul Hertz and Arthur Roberts.RAI continues to be an important part of the therapeutic armamentarium for advanced thyroid cancer in both adults and children.
DOI: 10.1007/s00259-023-06420-z
Authors: Lisa Bodei, R. Michael Tuttle, Ravinder K. Grewal, Audrey Mauguen, Finn Augensen, Murad Abusamra, Sonia Mahajan, Vetri Sudar Jayaprakasam, Joseph R. Osborne, Sofia Haque, Bernadette Z. Y. Wong, Ronald A. Ghossein, James Fagin, Heiko Schӧder, Alan Ho, John L. Humm, Steven M. Larson
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,990
OpenAlex ID: W4386757109
Cites: 13
Cited by: 12
Related to: 10